AstraZeneca Plc - Company Profile
Powered by 
All the sales intelligence you need on AstraZeneca Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how AstraZeneca Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with AstraZeneca Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreThe following section provides information on AstraZeneca Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into AstraZeneca Plc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Pascal Claude Roland Soriot
Chief Executive Officer; Director Executive BoardMr. Pascal Claude Roland Soriot has been the Chief Executive Officer and Director of the company since 2012. Prior to this, he served as the Chief Operating Officer of Roche’s pharmaceuticals and Chief Executive Officer of Genentech. Currently, Mr. Soriot also serves on the Board of Agilent Technologies Inc and Sustainable Markets Initiative Ltd.
Aradhana Sarin
Chief Financial Officer; Director Executive BoardMs. Aradhana Sarin has been the Chief Financial Officer and Director of the company since 2021. Prior to this, she served as the Chief Financial Officer of Alexion. Ms. Sarin has also served with Citi Global Banking, UBS, and JP Morgan. Currently, she serves on the Board of Governors of the American Red Cross and as an Independent Director and Audit Committee member of Anheuser-Busch InBev.
Marc Dunoyer
Chief Executive Officer - Alexion; Chief Strategy Officer Senior ManagementMr. Marc Dunoyer has been the Chief Strategy Officer of the company and Chief Executive Officer of Alexion since 2021. Prior to this, he served as Executive Vice President of Global Product and Portfolio Strategy, Global Head of Rare Diseases at GSK, and as Chairman of GSK Japan. Mr. Dunoyer has also served with Roussel Uclaf and Hoechst Marion Roussel. Currently, he also serves a member of the Boards of JCR Pharmaceuticals and Cellectis.
Pam P. Cheng
Chief Sustainability Officer; Executive Vice President - Operations and Information Technology Senior ManagementMs. Pam P. Cheng has been the Executive Vice President of Global Operations and Information Technology, and Chief Sustainability Officer of the company since 2023. Prior to this, she served as Head of Global Supply Chain Management & Logistics for Merck and as President of MSD China for Merck. Ms. Cheng has also served with Universal Oil Products, Union Carbide Corp, and GAF Chemicals. Currently, she also serves as Non-Executive Director of the Smiths Group plc Board; Trustee Member of the Board for Stevens Institute of Technology; and as an Advisor to the International Society of Pharmaceutical Engineering BoD.
Jeff Pott
Chief Human Resources Officer; General Counsel; Chief Compliance Officer Senior ManagementMr. Jeff Pott has been the General Counsel, Chief Compliance Officer, and Chief Human Resources Officer of the company since 2023. Prior to this, he served Chief Human Resources Officer and General Counsel of the company. Mr. has also worked in various litigation roles within the company and with Drinker Biddle and Reath LLP.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer